Literature DB >> 6194119

Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis.

J S Lam, L M Mutharia, R E Hancock, N Høiby, K Lam, L Baek, J W Costerton.   

Abstract

By crossed immunoelectrophoresis 36 different anode-migrating antigens were demonstrated in sonicated antigen preparations of Pseudomonas aeruginosa. We numbered these antigens to establish a reference precipitin pattern. Antigen no. 31 was identified as the lipopolysaccharide (LPS) antigen, because it was found to be responsible for the O-group specificity and because it reacted with anti-LPS monoclonal antibodies and with Limulus amoebocyte lysate. Purified outer membrane proteins F (porin), H2, and I used as antigens formed precipitins with the reference antibodies, thus establishing their antigenicity. LPS that copurified with protein F and slightly contaminated protein H2 was detectable as an extra precipitin (antigen no. 31). The use of monoclonal antibodies specific for smooth LPS and rough LPS revealed different antigenic determinants in the LPS molecule and suggested that antigen no. 5 could be the core region of the LPS which is equivalent to the rough LPS. Antibodies against these outer membrane antigens were detected in patients with chronic P. aeruginosa pneumonia and in patients with acute P. aeruginosa bacteremia. Antibodies with the same specificity were also found in rats chronically infected with P. aeruginosa 7 days postinfection. This demonstrates the surface accessibility and antigenic reactivity of outer membrane antigens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194119      PMCID: PMC264528          DOI: 10.1128/iai.42.1.88-98.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Immunochemical analysis of inner and outer membranes of Escherichia coli by crossed immunoelectrophoresis.

Authors:  C J Smyth; J Siegel; M R Salton; P Owen
Journal:  J Bacteriol       Date:  1978-01       Impact factor: 3.490

2.  Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer.

Authors:  S C Schimpff; W H Greene; V M Young; P H Wiernik
Journal:  Eur J Cancer       Date:  1973-06       Impact factor: 9.162

3.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

Review 4.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1977

5.  Crossed-line immunoelectrophoresis (73, 76).

Authors:  J Kroll
Journal:  Scand J Immunol Suppl       Date:  1973

6.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

7.  Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel.

Authors:  N Hoiby; N H Axelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-06

8.  Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification.

Authors:  O S Mikkelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

9.  Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients.

Authors:  S C Schimpff; M Moody; V M Young
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

10.  Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili.

Authors:  T M Buchanan; W A Pearce; G K Schoolnik; R J Arko
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

View more
  21 in total

1.  Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.

Authors:  M M Brett; A T Ghoneim; J M Littlewood; M S Losowsky
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

2.  Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F.

Authors:  R E Hancock; L M Mutharia; E C Mouat
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

3.  Pseudomonas aeruginosa immunotherapy.

Authors:  J E Pennington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

4.  Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; T McVeigh; P Owen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Visualization of Pseudomonas aeruginosa O antigens by using a protein A-dextran-colloidal gold conjugate with both immunoglobulin G and immunoglobulin M monoclonal antibodies.

Authors:  J S Lam; M Y Lam; L A MacDonald; R E Hancock
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

6.  Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis.

Authors:  T R de Kievit; J S Lam
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

7.  Rat model of experimental bacterial prostatitis.

Authors:  J C Nickel; M E Olson; J W Costerton
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 8.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

9.  Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen.

Authors:  S Sethi; S L Hill; T F Murphy
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; N Høiby; G H Shand; R S Conrad; C Galanos
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.